• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

访谈。Advanced BioHealing 的故事:将生物工程组织产品商业化。托泽先生接受了助理委托编辑艾米丽·卡尔梅-西摩的采访。

Interview. The story of Advanced BioHealing: commercializing bioengineered tissue products. Mr Tozer speaks to Emily Culme-Seymour, Assistant Commissioning Editor.

机构信息

Advanced BioHealing, 36 Church Lane, Westport, CT 06880, USA.

出版信息

Regen Med. 2011 Mar;6(2):157-61. doi: 10.2217/rme.11.1.

DOI:10.2217/rme.11.1
PMID:21391848
Abstract

Dean Tozer is Senior Vice President at Advanced BioHealing, Inc. (ABH), overseeing marketing, corporate development, government affairs, product development, various regulatory functions and international expansion. After completing his Bachelor of Commerce from Saint Mary's University in Halifax, Canada, Mr Tozer spent 10 years in the global pharmaceutical industry, primarily with G.D. Searle (a division of Monsanto) where he had a wide variety of roles in Global Marketing, Sales, Business Redesign, and Accounting and Finance. Mr Tozer then worked as a consultant to the biopharmaceutical industry, assisting start-up organizations in developing commercial strategies for both pharmaceutical products and biomedical devices, prior to joining ABH in March 2006 as Vice President of Marketing & Corporate Development. In addition to his leadership role at ABH, Mr Tozer currently serves as an officer and board member for the Alliance for Regenerative Medicine, a Washington DC-based organization formed to advance regenerative medicine by representing and supporting the community of companies, academic research institutions, patient advocacy groups, foundations, and other organizations before the Congress, federal agencies and the general public.

摘要

迪恩·托泽尔(Dean Tozer)是先进生物愈合公司(ABH)的高级副总裁,负责监督营销、企业发展、政府事务、产品开发、各种监管职能和国际扩张。在加拿大哈利法克斯的圣玛丽大学完成商业学士学位后,托泽尔先生在全球制药行业工作了 10 年,主要在 G.D.塞尔(孟山都的一个部门)工作,在那里他在全球营销、销售、业务重新设计以及会计和财务方面担任了各种职务。之后,他作为一名顾问为生物制药行业服务,协助初创组织制定药品和生物医学设备的商业战略,之后于 2006 年 3 月加入 ABH 担任营销和企业发展副总裁。除了在 ABH 的领导角色外,托泽尔先生目前还担任位于华盛顿特区的再生医学联盟的官员和董事会成员,该组织的成立旨在通过在国会、联邦机构和公众面前代表和支持公司、学术研究机构、患者权益团体、基金会和其他组织的社区来推进再生医学。

相似文献

1
Interview. The story of Advanced BioHealing: commercializing bioengineered tissue products. Mr Tozer speaks to Emily Culme-Seymour, Assistant Commissioning Editor.访谈。Advanced BioHealing 的故事:将生物工程组织产品商业化。托泽先生接受了助理委托编辑艾米丽·卡尔梅-西摩的采访。
Regen Med. 2011 Mar;6(2):157-61. doi: 10.2217/rme.11.1.
2
Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour.访谈:基于细胞的治疗和再生医学的商业翻译:经验学习。访谈者:艾米丽·卡尔梅-西摩。
Regen Med. 2011 Jul;6(4):431-5. doi: 10.2217/rme.11.40.
3
The bioprocessing of stem cells: how to reach the clinic. Interviewed by Emily Culme-Seymour.干细胞的生物处理:如何进入临床。艾米丽·卡尔梅-西摩采访。
Regen Med. 2013 Jul;8(4):409-12. doi: 10.2217/rme.13.31.
4
Navigating the clinical trial pathway: Conception, design, execution, and results dissemination.探索临床试验路径:构思、设计、实施及结果传播。
Surgery. 2017 Mar;161(3):576-583. doi: 10.1016/j.surg.2016.06.061.
5
Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.组织工程/再生医学产品商业化中的障碍:政府资助机构和金融行业的试点调查。
Tissue Eng Part A. 2012 Nov;18(21-22):2187-94. doi: 10.1089/ten.TEA.2012.0186. Epub 2012 Sep 27.
6
Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry.再生医学在产学研边界的探索:对机构、企业家和产业的影响。
Adv Exp Med Biol. 2018;1098:213-236. doi: 10.1007/978-3-319-97421-7_12.
7
The commercialization of regenerative medicine into a routine healthcare offering. Interview by Emily Culme-Seymour.再生医学商业化成为常规医疗服务。艾米丽·卡尔姆 - 西摩访谈
Regen Med. 2013 May;8(3):251-6. doi: 10.2217/rme.13.19.
8
Tissue engineering/regenerative medicine ventures should invest early in market research to understand the future market's needs.组织工程/再生医学企业应尽早投入市场调研,以了解未来市场的需求。
Tissue Eng Part B Rev. 2013 Apr;19(2):97-8. doi: 10.1089/ten.TEB.2012.0728. Epub 2013 Feb 19.
9
Interview with Lisa Shipley. Interviewed by Lisa Parks.对丽莎·希普利的采访。采访者为丽莎·帕克斯。
Bioanalysis. 2013 Aug;5(15):1819-20. doi: 10.4155/bio.13.129.
10
Bioactive wound healing, bioaesthetics and biosurgery: three pillars of product development. Interview with Geoff MacKay.生物活性伤口愈合、生物美学与生物外科手术:产品开发的三大支柱。对杰夫·麦凯的采访。
Regen Med. 2006 Mar;1(2):169-74. doi: 10.2217/17460751.1.2.169.